Genesis IBRC India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 17, 2025, 9:23 pm

Market Cap	23.8 Cr.
Current Price	18.3
High / Low	18.3/10.2
Stock P/E
Book Value	6.58
Dividend Yield	0.00 %
ROCE	54.8 %
ROE	54.8 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Genesis IBRC India Ltd

Competitors of Genesis IBRC India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Genomic Valley Biotech Ltd	17.7 Cr.	58.0	108/28.4	44.3	12.5	0.00 %	0.57 %	0.57 %	10.0
Genesis IBRC India Ltd	23.8 Cr.	18.3	18.3/10.2		6.58	0.00 %	54.8 %	54.8 %	10.0
Shreeoswal Seeds & Chemicals Ltd	123 Cr.	13.5	40.8/12.4		4.13	0.00 %	0.62 %	9.84 %	2.00
Nath Bio-Genes (India) Ltd	302 Cr.	159	264/142	7.24	339	1.26 %	6.85 %	6.23 %	10.0
Continental Seeds and Chemicals Ltd	36.4 Cr.	33.1	70.2/20.9		21.8	0.00 %	10.0 %	18.0 %	10.0
Industry Average	212.50 Cr	56.38		25.77	76.80	0.25%	14.57%	17.89%	8.40

All Competitor Stocks of Genesis IBRC India Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.67	0.00
Expenses	0.02	0.03	0.05	0.01	0.02	0.05	0.06	0.02	0.02	3.69	0.10	0.02	0.03
Operating Profit	-0.02	-0.03	-0.05	-0.01	-0.02	-0.05	-0.06	-0.02	-0.02	-3.69	-0.10	3.65	-0.03
OPM %												99.46%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.02	-0.03	-0.05	-0.01	-0.02	-0.05	-0.06	-0.02	-0.02	-3.69	-0.10	3.65	-0.03
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Profit	-0.02	-0.03	-0.05	-0.01	-0.02	-0.05	-0.06	-0.02	-0.02	-3.69	-0.10	3.65	-0.03
EPS in Rs	-0.02	-0.02	-0.04	-0.01	-0.02	-0.04	-0.05	-0.02	-0.02	-2.84	-0.08	2.81	-0.02

Last Updated: March 4, 2025, 12:11 pm

Below is a detailed analysis of the quarterly data for Genesis IBRC India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.67 Cr. (Sep 2024) to ₹0.00 Cr., marking a decrease of 3.67 Cr..
For Expenses, as of Dec 2024, the value is ₹0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Sep 2024) to ₹0.03 Cr., marking an increase of ₹0.01 Cr..
For Operating Profit, as of Dec 2024, the value is ₹-0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.65 Cr. (Sep 2024) to ₹-0.03 Cr., marking a decrease of 3.68 Cr..
For OPM %, as of Dec 2024, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 99.46% (Sep 2024) to 0.00%, marking a decrease of 99.46%.
For Other Income, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹-0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.65 Cr. (Sep 2024) to ₹-0.03 Cr., marking a decrease of 3.68 Cr..
For Tax %, as of Dec 2024, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
For Net Profit, as of Dec 2024, the value is ₹-0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.65 Cr. (Sep 2024) to ₹-0.03 Cr., marking a decrease of 3.68 Cr..
For EPS in Rs, as of Dec 2024, the value is -0.02. The value appears to be declining and may need further review. It has decreased from ₹2.81 (Sep 2024) to -0.02, marking a decrease of ₹2.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 3:54 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	0.22	0.39	0.78	0.00	0.00	0.29	0.05	0.00	0.00	0.00	0.00	0.00	3.67
Expenses	0.50	0.55	0.93	0.07	0.07	0.49	0.10	0.10	0.12	0.12	0.14	3.80	3.84
Operating Profit	-0.28	-0.16	-0.15	-0.07	-0.07	-0.20	-0.05	-0.10	-0.12	-0.12	-0.14	-3.80	-0.17
OPM %	-127.27%	-41.03%	-19.23%			-68.97%	-100.00%						-4.63%
Other Income	0.23	0.01	-0.09	0.42	0.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.21	0.18	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.26	-0.33	-0.45	0.35	0.00	-0.20	-0.05	-0.10	-0.12	-0.12	-0.14	-3.80	-0.17
Tax %	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Profit	-0.26	-0.33	-0.44	0.35	0.00	-0.20	-0.05	-0.10	-0.12	-0.12	-0.14	-3.80	-0.17
EPS in Rs	-0.86	-1.09	-0.62	0.36	0.00	-0.15	-0.04	-0.08	-0.09	-0.09	-0.11	-2.92	-0.13
Dividend Payout %	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-26.92%	-33.33%	179.55%	-100.00%	75.00%	-100.00%	-20.00%	0.00%	-16.67%	-2614.29%
Change in YoY Net Profit Growth (%)	0.00%	-6.41%	212.88%	-279.55%	175.00%	-175.00%	80.00%	20.00%	-16.67%	-2597.62%

Genesis IBRC India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-13%

Stock Price CAGR
10 Years:	2%
5 Years:	20%
3 Years:	25%
1 Year:	70%

Return on Equity
10 Years:	-6%
5 Years:	-10%
3 Years:	-16%
Last Year:	-55%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 1:37 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	3.02	3.02	7.12	9.74	10.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00
Reserves	-2.92	-3.25	-3.70	-3.35	-3.35	-3.55	-3.70	-3.80	-3.92	-4.04	-4.17	-7.97	-4.42
Borrowings	0.61	0.61	0.17	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.74	0.90	0.93	0.51	0.03	0.07	0.08	0.12	0.12	0.13	0.14	0.18	0.25
Total Liabilities	1.45	1.28	4.52	7.10	6.68	9.52	9.38	9.32	9.20	9.09	8.97	5.21	8.83
Fixed Assets	1.28	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	4.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.17	0.18	4.52	7.10	6.68	4.86	9.38	9.32	9.20	9.09	8.97	5.21	8.83
Total Assets	1.45	1.28	4.52	7.10	6.68	9.52	9.38	9.32	9.20	9.09	8.97	5.21	8.83

Below is a detailed analysis of the balance sheet data for Genesis IBRC India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹13.00 Cr..
For Reserves, as of Sep 2024, the value is ₹-4.42 Cr.. The value appears to be improving (becoming less negative). It has improved from ₹-7.97 Cr. (Mar 2024) to ₹-4.42 Cr., marking an improvement of ₹3.55 Cr..
For Borrowings, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹0.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹0.18 Cr. (Mar 2024) to ₹0.25 Cr., marking an increase of 0.07 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹8.83 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹5.21 Cr. (Mar 2024) to ₹8.83 Cr., marking an increase of 3.62 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹8.83 Cr.. The value appears strong and on an upward trend. It has increased from ₹5.21 Cr. (Mar 2024) to ₹8.83 Cr., marking an increase of 3.62 Cr..
For Total Assets, as of Sep 2024, the value is ₹8.83 Cr.. The value appears strong and on an upward trend. It has increased from ₹5.21 Cr. (Mar 2024) to ₹8.83 Cr., marking an increase of 3.62 Cr..

However, the Borrowings (0.00 Cr.) are higher than the Reserves (₹-4.42 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-0.13	4.98	-4.86	-2.64	-0.25	1.68	-4.69	0.01	-0.12	-0.12	-0.09	0.00
Cash from Investing Activity +	0.00	0.00	0.77	0.00	0.00	-4.66	4.66	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activity +	0.12	0.71	4.10	2.62	0.26	3.00	0.00	0.00	0.12	0.12	0.09	0.00
Net Cash Flow	-0.01	5.69	0.01	-0.02	0.01	0.02	-0.03	0.01	0.00	0.00	-0.01	0.00

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-0.89	-0.77	-0.32	-0.27	-0.07	-0.20	-0.05	-0.10	-0.12	-0.12	-0.14	-3.80

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	149.32	28.08	229.29			62.93	292.00
Inventory Days	134.47	104.29	0.00			0.00
Days Payable	172.89	156.43
Cash Conversion Cycle	110.90	-24.07	229.29			62.93	292.00
Working Capital Days	-945.68	-701.92	1,665.90			5,991.03	67,890.00
ROCE %	-63.23%	-60.55%	-16.62%	6.88%	0.00%	-2.48%	-0.53%	-1.08%	-1.31%	-1.33%	-1.57%	-54.83%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%	11.33%
Public	88.67%	88.67%	88.68%	88.68%	88.68%	88.68%	88.68%	88.68%	88.68%	88.68%	88.68%	88.68%
No. of Shareholders	1,745	1,746	1,747	1,746	1,749	1,748	1,745	1,752	1,749	1,750	1,751	1,751

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 18
FaceValue	10.00
Basic EPS (Rs.)	-0.03
Diluted EPS (Rs.)	-0.03
Cash EPS (Rs.)	0.04
Book Value[Excl.RevalReserv]/Share (Rs.)	7.39
Book Value[Incl.RevalReserv]/Share (Rs.)	7.39
Revenue From Operations / Share (Rs.)	3.33
PBDIT / Share (Rs.)	0.14
PBIT / Share (Rs.)	0.06
PBT / Share (Rs.)	0.04
Net Profit / Share (Rs.)	-0.02
NP After MI And SOA / Share (Rs.)	-0.02
PBDIT Margin (%)	4.20
PBIT Margin (%)	2.02
PBT Margin (%)	1.41
Net Profit Margin (%)	-0.78
NP After MI And SOA Margin (%)	-0.78
Return on Networth / Equity (%)	-0.35
Return on Capital Employeed (%)	0.87
Return On Assets (%)	-0.27
Current Ratio (X)	3.24
Quick Ratio (X)	3.00
Interest Coverage Ratio (X)	6.83
Interest Coverage Ratio (Post Tax) (X)	-0.27
Enterprise Value (Cr.)	6.58
EV / Net Operating Revenue (X)	1.52
EV / EBITDA (X)	36.12
MarketCap / Net Operating Revenue (X)	1.59
Price / BV (X)	0.71
Price / Net Operating Revenue (X)	1.59

After reviewing the key financial ratios for Genesis IBRC India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
For Basic EPS (Rs.), as of Mar 18, the value is -0.03. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Diluted EPS (Rs.), as of Mar 18, the value is -0.03. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Cash EPS (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 7.39. No previous period data is available for comparison.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 7.39. No previous period data is available for comparison.
For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 3.33. No previous period data is available for comparison.
For PBDIT / Share (Rs.), as of Mar 18, the value is 0.14. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For PBIT / Share (Rs.), as of Mar 18, the value is 0.06. This value is within the healthy range. No previous period data is available for comparison.
For PBT / Share (Rs.), as of Mar 18, the value is 0.04. This value is within the healthy range. No previous period data is available for comparison.
For Net Profit / Share (Rs.), as of Mar 18, the value is -0.02. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is -0.02. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For PBDIT Margin (%), as of Mar 18, the value is 4.20. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBIT Margin (%), as of Mar 18, the value is 2.02. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBT Margin (%), as of Mar 18, the value is 1.41. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Net Profit Margin (%), as of Mar 18, the value is -0.78. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For NP After MI And SOA Margin (%), as of Mar 18, the value is -0.78. This value is below the healthy minimum of 8. No previous period data is available for comparison.
For Return on Networth / Equity (%), as of Mar 18, the value is -0.35. This value is below the healthy minimum of 15. No previous period data is available for comparison.
For Return on Capital Employeed (%), as of Mar 18, the value is 0.87. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Return On Assets (%), as of Mar 18, the value is -0.27. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Current Ratio (X), as of Mar 18, the value is 3.24. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
For Quick Ratio (X), as of Mar 18, the value is 3.00. This value exceeds the healthy maximum of 2. No previous period data is available for comparison.
For Interest Coverage Ratio (X), as of Mar 18, the value is 6.83. This value is within the healthy range. No previous period data is available for comparison.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is -0.27. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Enterprise Value (Cr.), as of Mar 18, the value is 6.58. No previous period data is available for comparison.
For EV / Net Operating Revenue (X), as of Mar 18, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
For EV / EBITDA (X), as of Mar 18, the value is 36.12. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.59. This value is within the healthy range. No previous period data is available for comparison.
For Price / BV (X), as of Mar 18, the value is 0.71. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.59. This value is within the healthy range. No previous period data is available for comparison.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Genesis IBRC India Ltd as of March 12, 2025 is: ₹44.14

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Genesis IBRC India Ltd is Undervalued by 141.20% compared to the current share price 18.30

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Genesis IBRC India Ltd as of March 12, 2025 is: 43.80

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Genesis IBRC India Ltd is Undervalued by 139.34% compared to the current share price 18.30

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -0.78%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -131.22, which is a positive sign.	The stock has a low average ROCE of -16.39%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 55.92, which may not be favorable. The company has higher borrowings (0.12) compared to reserves (-4.01), which may suggest financial risk. The company has not shown consistent growth in sales (0.42) and profit (-0.41).

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Genesis IBRC India Ltd:
1. Net Profit Margin: -0.78%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 0.87% (Industry Average ROCE: 14.57%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: -0.35% (Industry Average ROE: 17.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -0.27
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 25.77)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Genesis IBRC India Ltd. is a Public Limited Listed company incorporated on 23/10/1992 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L47733AP1992PLC107068 and registration number is 107068. Currently Company is involved in the business activities of Manufacture of other animal feeds. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.00 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Seeds/Tissue Culture/Bio Technology	Flat No.401, VVN Residency, 40-A, Ashok Nagar, Eluru Andhra Pradesh 534002	csgenesisiil@gmail.com www.genesisiil.com

Management
Name	Position Held
Mr. Mohammed Baba	Independent Director
Mr. Balakrishna Koppula	Whole Time Director
Mrs. Vanitha Nagulavari	Non Executive Director
Mr. Prasada Rao Kalluri	Independent Director

FAQ

What is Genesis IBRC India Ltd's true worth and is it a good investment?

Let's break down Genesis IBRC India Ltd's valuation simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 21 February 2025:

Calculated Fair Value: ₹44.14
Current Market Price: ₹18.30
Variance: 141.20% higher

This suggests Genesis IBRC India Ltd is currently undervalued by 141.20%. For context:

Market Cap: 23.8 Cr.
52-Week Range: 18.3/10.2
Reserves (Sep 2024): ₹-4.42 Cr
Liabilities: 8.83 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Genesis IBRC India Ltd?

The Market Cap of Genesis IBRC India Ltd is 23.8 Cr..

What is the current Stock Price of Genesis IBRC India Ltd as on 21 February 2025?

The current stock price of Genesis IBRC India Ltd as on 21 February 2025 is ₹18.3.

What is the High / Low of Genesis IBRC India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Genesis IBRC India Ltd stocks is 18.3/10.2.

What is the Stock P/E of Genesis IBRC India Ltd?

The Stock P/E of Genesis IBRC India Ltd is .

What is the Book Value of Genesis IBRC India Ltd?

The Book Value of Genesis IBRC India Ltd is 6.58.

What is the Dividend Yield of Genesis IBRC India Ltd?

The Dividend Yield of Genesis IBRC India Ltd is 0.00 %.

What is the ROCE of Genesis IBRC India Ltd?

The ROCE of Genesis IBRC India Ltd is 54.8 %.

What is the ROE of Genesis IBRC India Ltd?

The ROE of Genesis IBRC India Ltd is 54.8 %.

What is the Face Value of Genesis IBRC India Ltd?

The Face Value of Genesis IBRC India Ltd is 10.0.